The role of peroxisome proliferator‐activated receptor γ in lipid metabolism and inflammation in atherosclerosis
出版年份 2023 全文链接
标题
The role of peroxisome proliferator‐activated receptor γ in lipid metabolism and inflammation in atherosclerosis
作者
关键词
-
出版物
CELL BIOLOGY INTERNATIONAL
Volume 47, Issue 9, Pages 1469-1487
出版商
Wiley
发表日期
2023-06-28
DOI
10.1002/cbin.12065
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multistability in Macrophage Activation Pathways and Metabolic Implications
- (2022) Carsten Geiß et al. Cells
- Peroxisome proliferator-activated receptor-gamma (PPARγ) and its immunomodulation function: current understanding and future therapeutic implications
- (2022) Carlos Antonio Trindade da Silva et al. Expert Review of Clinical Pharmacology
- The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators
- (2022) Liqin Yin et al. Frontiers in Physiology
- Macrophage Polarization in Atherosclerosis
- (2022) Sahar Eshghjoo et al. Genes
- Mouse models of atherosclerosis in translational research
- (2022) Iqra Ilyas et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions
- (2022) Nanfei Yang et al. CELL DEATH AND DIFFERENTIATION
- Low-density lipoprotein particles in atherosclerosis
- (2022) Ya-Nan Qiao et al. Frontiers in Physiology
- Matrix metalloproteinase 9 a potential major player connecting atherosclerosis and osteoporosis in high fat diet fed rats
- (2021) Maha Sabry et al. PLoS One
- Cardiolipin-mediated PPARγ S112 phosphorylation impairs IL-10 production and inflammation resolution during bacterial pneumonia
- (2021) Mayank Garg et al. Cell Reports
- PPARγ-induced upregulation of subcutaneous fat adiponectin secretion, glyceroneogenesis and BCAA oxidation requires mTORC1 activity
- (2021) Maynara L. Andrade et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms
- (2021) Khojasteh Malekmohammad et al. Frontiers in Cardiovascular Medicine
- ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis
- (2021) Michinori Matsuo JOURNAL OF PHARMACOLOGICAL SCIENCES
- FABP4 knockdown suppresses inflammation, apoptosis and extracellular matrix degradation in IL-1β-induced chondrocytes by activating PPARγ to regulate the NF-κB signaling pathway
- (2021) Huajie Mao et al. Molecular Medicine Reports
- TNF-Mediated Inhibition of Classical Swine Fever Virus Replication Is IRF1-, NF-κB- and JAK/STAT Signaling-Dependent
- (2021) Matthias Liniger et al. Viruses-Basel
- Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation
- (2021) Zhao Gao et al. Frontiers in Pharmacology
- WSF-7 Inhibits Obesity-Mediated PPARγ Phosphorylation and Improves Insulin Sensitivity in 3T3-L1 Adipocytes
- (2020) Yudian Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The role of JAK/STAT signaling pathway and its inhibitors in diseases
- (2020) Ping Xin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation
- (2020) Xiaofei Gu et al. CELLULAR SIGNALLING
- Insights into PPARγ Phosphorylation and Its Inhibition Mechanism
- (2020) Roberta Montanari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Macrophage M1/M2 polarization
- (2020) Chen Yunna et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review
- (2020) Yu Liu et al. JOURNAL OF AUTOIMMUNITY
- Arteriosclerosis e inflamación. Nuevos enfoques terapéuticos
- (2020) Juan Pedro-Botet et al. MEDICINA CLINICA
- Obesity-Linked PPARγ S273 Phosphorylation Promotes Insulin Resistance through Growth Differentiation Factor 3
- (2020) Jessica A. Hall et al. Cell Metabolism
- PPARγ S273 Phosphorylation Modifies the Dynamics of Coregulator Proteins Recruitment
- (2020) Marieli Mariano Gonçalves Dias et al. Frontiers in Endocrinology
- M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment
- (2019) Ying Bi et al. NEURAL PLASTICITY
- PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression
- (2019) Guozhu Ye et al. Cell Death & Disease
- Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis
- (2019) Giuliano Generoso et al. Current Opinion in Endocrinology Diabetes and Obesity
- Monocytes and macrophages in atherogenesis
- (2019) Jaume Amengual et al. CURRENT OPINION IN LIPIDOLOGY
- Resistin up-regulates LPL expression through the PPARγ-dependent PI3K/AKT signaling pathway impacting lipid accumulation in RAW264.7 macrophages
- (2019) Bi Li et al. CYTOKINE
- Procyanidin B2 Activates PPARγ to Induce M2 Polarization in Mouse Macrophages
- (2019) Ying Tian et al. Frontiers in Immunology
- Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
- (2019) Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TRIM7 promotes proliferation and migration of vascular smooth muscle cells in atherosclerosis through activating c‐Jun/AP‐1
- (2019) Rongjing Ji et al. IUBMB LIFE
- Vascular Macrophages in Atherosclerosis
- (2019) Hailin Xu et al. Journal of Immunology Research
- Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
- (2018) Verena Hiebl et al. BIOTECHNOLOGY ADVANCES
- CD36 and lipid metabolism in the evolution of atherosclerosis
- (2018) Lei Zhao et al. BRITISH MEDICAL BULLETIN
- Signaling Pathways in Inflammation and Anti-inflammatory Therapies
- (2018) Yiu To Yeung et al. CURRENT PHARMACEUTICAL DESIGN
- MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis
- (2018) Jerry R. Colca et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting RAW 264.7 macrophages (M1 type) with Withaferin-A decorated mannosylated liposomes induces repolarization via downregulation of NF-κB and controlled elevation of STAT-3
- (2018) Manoj Kumar Neog et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Functional Regulation of PPARs through Post-Translational Modifications
- (2018) Reinhard Brunmeir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
- (2018) Xavier Palomer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
- (2018) Shreekrishna Lamichane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liver X receptors in lipid signalling and membrane homeostasis
- (2018) Bo Wang et al. Nature Reviews Endocrinology
- The IL-4/STAT6/PPARγ signaling axis is driving the expansion of the RXR heterodimer cistrome, providing complex ligand responsiveness in macrophages
- (2018) Bence Daniel et al. NUCLEIC ACIDS RESEARCH
- Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ
- (2018) Jun Young Jang et al. Scientific Reports
- Peroxisome Proliferator Activated Receptor Gamma Controls Mature Brown Adipocyte Inducibility through Glycerol Kinase
- (2018) David Lasar et al. Cell Reports
- 9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4
- (2018) Venkat Vangaveti et al. Therapeutic Advances in Endocrinology and Metabolism
- Modulation of the Inflammatory Status of Macrophages and Their Paracrine Effect on the Sensitivity of Adipocytes to Insulin with Sirtuin and PPARγ Receptor Activators
- (2018) Yu. S. Stafeev et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation
- (2018) Antonio Laghezza et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis
- (2018) Anna Reustle et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPARγ overexpression regulates cholesterol metabolism in human L02 hepatocytes
- (2018) Tao Han et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Liver X receptors link lipid metabolism and inflammation
- (2017) Ira G. Schulman FEBS LETTERS
- Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression
- (2017) Karishma Rahman et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms of foam cell formation in atherosclerosis
- (2017) Dimitry A. Chistiakov et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Monocyte and macrophage immunometabolism in atherosclerosis
- (2017) Laszlo Groh et al. Seminars in Immunopathology
- Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPARγ
- (2017) De-Si Pan et al. PPAR Research
- Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease
- (2017) Wenjing Luo et al. Scientific Reports
- ROS via BTK-p300-STAT1-PPARγ signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation
- (2017) Sivareddy Kotla et al. Redox Biology
- Selective PPAR modulators (SPPARs) may fill the need for treatment of the atherogenic dyslipidemia of insulin resistance and type 2 diabetes: Can they reduce the associated cardiac risk?
- (2016) Germán Camejo ATHEROSCLEROSIS
- Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling
- (2016) Islam Osman et al. BIOCHEMICAL PHARMACOLOGY
- Macrophage Phenotype and Function in Different Stages of Atherosclerosis
- (2016) Ira Tabas et al. CIRCULATION RESEARCH
- Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARγ-dependent pathway
- (2016) Tao Zhu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- 6-Gingerol Suppresses Adipocyte-Derived Mediators of Inflammation In Vitro and in High-Fat Diet-Induced Obese Zebra Fish
- (2016) Jia Choi et al. PLANTA MEDICA
- Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals
- (2016) Tetsuya Kimura et al. Nature Communications
- M1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis
- (2016) Monica de Gaetano et al. Frontiers in Immunology
- Combined Sub-Optimal Doses of Rosuvastatin and Bexarotene Impair Angiotensin II-Induced Arterial Mononuclear Cell Adhesion Through Inhibition of Nox5 Signaling Pathways and Increased RXR/PPARα and RXR/PPARγ Interactions
- (2015) Paula Escudero et al. ANTIOXIDANTS & REDOX SIGNALING
- Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis
- (2015) Soo Lim et al. ATHEROSCLEROSIS
- Novel phosphorylation of PPARγ ameliorates obesity-induced adipose tissue inflammation and improves insulin sensitivity
- (2015) Sunsil Choi et al. CELLULAR SIGNALLING
- Role of Inflammatory Cells and Toll-Like Receptors in Atherosclerosis
- (2015) Anusha Seneviratne et al. Current Vascular Pharmacology
- Macrophage-mediated cholesterol handling in atherosclerosis
- (2015) Dimitry A. Chistiakov et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB
- (2015) Simone Marcone et al. Journal of Inflammation-London
- Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13
- (2015) Shanshan Gao et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
- (2015) Justin A. Lemkul et al. PLoS One
- Macrophage phenotypes in atherosclerosis
- (2014) Sophie Colin et al. IMMUNOLOGICAL REVIEWS
- A Novel Non-agonist Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand UHC1 Blocks PPARγ Phosphorylation by Cyclin-dependent Kinase 5 (CDK5) and Improves Insulin Sensitivity
- (2014) Sun-Sil Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: Crosstalk between NF-κB and PPAR-γ
- (2014) Youzhi Zhang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- FKBP51 Controls Cellular Adipogenesis through p38 Kinase-Mediated Phosphorylation of GRα and PPARγ
- (2014) Lance A. Stechschulte et al. MOLECULAR ENDOCRINOLOGY
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- Pioglitazone Treatment Reduces Adipose Tissue Inflammation through Reduction of Mast Cell and Macrophage Number and by Improving Vascularity
- (2014) Michael Spencer et al. PLoS One
- Overexpression of Angiopoietin-Like Protein 4 Protects Against Atherosclerosis Development
- (2013) Anastasia Georgiadi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Foam cells in atherosclerosis
- (2013) Xiao-Hua Yu et al. CLINICA CHIMICA ACTA
- M1 and M2 Macrophages: Oracles of Health and Disease
- (2013) Charles Mills CRITICAL REVIEWS IN IMMUNOLOGY
- Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPARγ/PGC-1α pathway and Insig1/2 expression in hepatocytes
- (2013) Amélie Rodrigue-Way et al. FASEB JOURNAL
- Regulation of energy metabolism by long-chain fatty acids
- (2013) Manabu T. Nakamura et al. PROGRESS IN LIPID RESEARCH
- A High-Fat Diet Increases IL-1, IL-6, and TNF-α Production by Increasing NF-κB and Attenuating PPAR-γ Expression in Bone Marrow Mesenchymal Stem Cells
- (2012) Mayara Cortez et al. INFLAMMATION
- ABCA1 Protein Enhances Toll-like Receptor 4 (TLR4)-stimulated Interleukin-10 (IL-10) Secretion through Protein Kinase A (PKA) Activation
- (2012) Loretta Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Retinoid X Receptor Agonists Impair Arterial Mononuclear Cell Recruitment through Peroxisome Proliferator-Activated Receptor- Activation
- (2012) M.-J. Sanz et al. JOURNAL OF IMMUNOLOGY
- Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase
- (2012) Dmitri Samovski et al. JOURNAL OF LIPID RESEARCH
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- PPARγ is an E3 ligase that induces the degradation of NFκB/p65
- (2012) Yongzhong Hou et al. Nature Communications
- Targeting inflammation by modulating the Jun/AP-1 pathway
- (2011) H. B. Schonthaler et al. ANNALS OF THE RHEUMATIC DISEASES
- Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist
- (2011) Tsuyoshi Goto et al. BIOCHEMICAL JOURNAL
- Fatty acid transport proteins, implications in physiology and disease
- (2011) Melissa Kazantzis et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- NF-κB, Inflammation, and Metabolic Disease
- (2011) Rebecca G. Baker et al. Cell Metabolism
- Differential Lipid Partitioning Between Adipocytes and Tissue Macrophages Modulates Macrophage Lipotoxicity and M2/M1 Polarization in Obese Mice
- (2011) Xavier Prieur et al. DIABETES
- Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
- (2011) Jang Hyun Choi et al. NATURE
- Peroxisome Proliferator-Activated Receptor γ Agonist Troglitazone Inhibits High Mobility Group Box 1 Expression in Endothelial Cells Via Suppressing Transcriptional Activity of Nuclear Factor κB and Activator Protein 1
- (2011) Min Gao et al. SHOCK
- Lipid signaling in the atherogenesis context
- (2010) A. N. Smirnov BIOCHEMISTRY-MOSCOW
- Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses
- (2010) Liu Kang et al. BIOCHIMIE
- Angptl4 Protects against Severe Proinflammatory Effects of Saturated Fat by Inhibiting Fatty Acid Uptake into Mesenteric Lymph Node Macrophages
- (2010) Laeticia Lichtenstein et al. Cell Metabolism
- Natural Angiogenesis Inhibitor Signals through Erk5 Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ)
- (2010) Dauren Biyashev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation
- (2009) Linda Slanec Higgins et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Functional cooperation between Stat-1 and ets-1 to optimize icam-1 gene transcription
- (2009) Julien Yockell-Lelièvre et al. Biochemistry and Cell Biology
- Casein-kinase-II-dependent phosphorylation of PPAR provokes CRM1-mediated shuttling of PPAR from the nucleus to the cytosol
- (2009) A. von Knethen et al. JOURNAL OF CELL SCIENCE
- Non-redundant roles for LXRα and LXRβ in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice
- (2009) Eric D. Bischoff et al. JOURNAL OF LIPID RESEARCH
- Posttranslational Modifications of PPAR-γ: Fine-tuning the Metabolic Master Regulator
- (2009) Olivier van Beekum et al. Obesity
- Structure and physiological functions of the human peroxisome proliferator-activated receptor γ
- (2008) Andrzej Zieleniak et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Regulation of Macrophage Functions by PPAR-α, PPAR-γ, and LXRs in Mice and Men
- (2008) Elena Rigamonti et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reassessing the Cardiovascular Risks and Benefits of Thiazolidinediones
- (2008) Andrew Zinn et al. CLINICAL CARDIOLOGY
- Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity
- (2008) Leonie Heilbronn et al. CURRENT PHARMACEUTICAL DESIGN
- Oxidized Low Density Lipoprotein Activates Peroxisome Proliferator-activated Receptor-α (PPARα) and PPARγ through MAPK-dependent COX-2 Expression in Macrophages
- (2008) Kayo Taketa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mat1 Inhibits Peroxisome Proliferator-Activated Receptor -Mediated Adipocyte Differentiation
- (2008) K. Helenius et al. MOLECULAR AND CELLULAR BIOLOGY
- Dok1 mediates high-fat diet–induced adipocyte hypertrophy and obesity through modulation of PPAR-γ phosphorylation
- (2008) Tetsuya Hosooka et al. NATURE MEDICINE
- Omega-3 Fatty Acids and PPARγin Cancer
- (2008) Iris J. Edwards et al. PPAR Research
- A hypothesis: Adiponectin mediates anti-atherosclerosis via adventitia-AMPK-iNOS pathway
- (2007) Xiao-jun Cai et al. MEDICAL HYPOTHESES
- Macrophages: An elusive yet emerging therapeutic target of atherosclerosis
- (2007) R.L. Tiwari et al. MEDICINAL RESEARCH REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now